Search Results - "HOENIGL, Martin"

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin by Hoenigl, Martin, Sprute, Rosanne, Egger, Matthias, Arastehfar, Amir, Cornely, Oliver A., Krause, Robert, Lass-Flörl, Cornelia, Prattes, Juergen, Spec, Andrej, Thompson, George R., Wiederhold, Nathan, Jenks, Jeffrey D.

“…The epidemiology of invasive fungal infections is changing, with new populations at risk and the emergence of resistance caused by the selective pressure from…”
Get full text

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance by Koehler, Philipp, Bassetti, Matteo, Chakrabarti, Arunaloke, Chen, Sharon C A, Colombo, Arnaldo Lopes, Hoenigl, Martin, Klimko, Nikolay, Lass-Flörl, Cornelia, Oladele, Rita O, Vinh, Donald C, Zhu, Li-Ping, Böll, Boris, Brüggemann, Roger, Gangneux, Jean-Pierre, Perfect, John R, Patterson, Thomas F, Persigehl, Thorsten, Meis, Jacques F, Ostrosky-Zeichner, Luis, White, P Lewis, Verweij, Paul E, Cornely, Oliver A

“…Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway epithelium, enabling aspergillus invasion. Reports of COVID-19-associated…”
Get full text

Treatment of Aspergillosis by Jenks, Jeffrey D, Hoenigl, Martin

“…Infections caused by spp. remain associated with high morbidity and mortality. While mold-active antifungal prophylaxis has led to a decrease of occurrence of…”
Get full text

Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions by Egger, Matthias, Bussini, Linda, Hoenigl, Martin, Bartoletti, Michele

“…First reports of cases and case series of COVID-19-associated pulmonary aspergillosis (CAPA) emerged during the first months of the pandemic. Prevalence rates…”
Get full text

Diagnosing COVID-19-associated pulmonary aspergillosis by Verweij, Paul E, Gangneux, Jean-Pierre, Bassetti, Matteo, Brüggemann, Roger J M, Cornely, Oliver A, Koehler, Philipp, Lass-Flörl, Cornelia, van de Veerdonk, Frank L, Chakrabarti, Arunaloke, Hoenigl, Martin

Get full text

HIV and Hepatitis C Virus Screening in the Emergency Department and Linkage to Care During COVID-19: Challenges and Solutions by Lara-Paez, George, Zuazo, Miriam, Blumenthal, Jill, Coyne, Christopher J., Hoenigl, Martin

Get full text

COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions? by Arastehfar, Amir, Carvalho, Agostinho, Nguyen, M. Hong, Hedayati, Mohammad Taghi, Netea, Mihai G., Perlin, David S., Hoenigl, Martin

“…The recent global pandemic of COVID-19 has predisposed a relatively high number of patients to acute respiratory distress syndrome (ARDS), which carries a risk…”
Get full text

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries by Hoenigl, Martin, Seidel, Danila, Carvalho, Agostinho, Rudramurthy, Shivaprakash M, Arastehfar, Amir, Gangneux, Jean-Pierre, Nasir, Nosheen, Bonifaz, Alexandro, Araiza, Javier, Klimko, Nikolai, Serris, Alexandra, Lagrou, Katrien, Meis, Jacques F, Cornely, Oliver A, Perfect, John R, White, P Lewis, Chakrabarti, Arunaloke

“…Reports of COVID-19-associated mucormycosis have been increasing in frequency since early 2021, particularly among patients with uncontrolled diabetes…”
Get full text

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From immunology to treatment by Arastehfar, Amir, Carvalho, Agostinho, van de Veerdonk, Frank L., Jenks, Jeffrey D., Koehler, Philipp, Krause, Robert, Cornely, Oliver A., S. Perlin, David, Lass-Flörl, Cornelia, Hoenigl, Martin

“…Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that…”
Get full text

Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium by Arastehfar, Amir, Gabaldón, Toni, Garcia-Rubio, Rocio, Jenks, Jeffrey D, Hoenigl, Martin, Salzer, Helmut J F, Ilkit, Macit, Lass-Flörl, Cornelia, Perlin, David S

“…The high clinical mortality and economic burden posed by invasive fungal infections (IFIs), along with significant agricultural crop loss caused by various…”
Get full text

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study by Hatzl, Stefan, Reisinger, Alexander C., Posch, Florian, Prattes, Juergen, Stradner, Martin, Pilz, Stefan, Eller, Philipp, Schoerghuber, Michael, Toller, Wolfgang, Gorkiewicz, Gregor, Metnitz, Philipp, Rief, Martin, Prüller, Florian, Rosenkranz, Alexander R., Valentin, Thomas, Krause, Robert, Hoenigl, Martin, Schilcher, Gernot

“…Abstract Background Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) emerged as important fungal complications in patients with…”
Get full text

Point‐of‐care diagnosis of invasive aspergillosis in non‐neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus‐specific Lateral Flow Device test in bronchoalveolar lavage by Jenks, Jeffrey D., Mehta, Sanjay R., Taplitz, Randy, Aslam, Saima, Reed, Sharon L., Hoenigl, Martin

“…Summary Background We compared new Aspergillus Galactomannan Lateral Flow Assay with the newly formatted Aspergillus‐specific Lateral Flow device tests for the…”
Get full text

Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology by Cornely, Oliver A., Hoenigl, Martin, Lass‐Flörl, Cornelia, Chen, Sharon C. ‐A., Kontoyiannis, Dimitrios P., Morrissey, C. Orla, Thompson, George R.

“…Summary Breakthrough invasive fungal infections (IFIs) have emerged as a significant problem in patients receiving systemic antifungals; however, consensus…”
Get full text

Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseases by von Lilienfeld-Toal, Marie, Vehreschild, Jörg Janne, Cornely, Oliver, Pagano, Livio, Compagno, Francesca, Hirsch, Hans H.

“…Since early 2020, the SARS-CoV-2 pandemic has a massive impact on health care systems worldwide. Patients with malignant diseases are assumed to be at…”
Get full text

Dark Mold Infections in Solid Organ Transplant Recipients by Boyer, Johannes, Kriegl, Lisa, Krause, Robert, Hoenigl, Martin

“…Purpose of Review Solid organ transplant (SOT) recipients are a high-risk population for invasive fungal infections. While infections with black molds are rare…”
Get full text

Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report by Prattes, Juergen, Valentin, Thomas, Hoenigl, Martin, Talakic, Emina, Reisinger, Alexander C., Eller, Philipp

“…It is not yet known, if critically ill COVID-19 patients are prone to fungal infections. We report a 69-year-old patient without typical risk factors for…”
Get full text

Fungal Infections Complicating COVID-19: With the Rain Comes the Spores by Talento, Alida Fe, Hoenigl, Martin

“…Within the last 12 months, coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spread globally to…”
Get full text

Race and ethnicity: Risk factors for fungal infections? by Jenks, Jeffrey D, Aneke, Chioma Inyang, Al-Obaidi, Mohanad M, Egger, Matthias, Garcia, Lorena, Gaines, Tommi, Hoenigl, Martin, Thompson, 3rd, George R

“…Racial and ethnic identities, largely understood as social rather than biologic constructs, may impact risk for acquiring infectious diseases, including fungal…”
Get full text

Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy by Zurl, Christoph, Hoenigl, Martin, Schulz, Eduard, Hatzl, Stefan, Gorkiewicz, Gregor, Krause, Robert, Eller, Philipp, Prattes, Juergen

“…Viral infections can cause acute respiratory distress syndrome (ARDS), consequently leading to susceptibility for secondary pulmonary infections. Over the past…”
Get full text

Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples by Heldt, Sven, Prattes, Juergen, Eigl, Susanne, Spiess, Birgit, Flick, Holger, Rabensteiner, Jasmin, Johnson, Gemma, Prüller, Florian, Wölfler, Albert, Niedrist, Tobias, Boch, Tobias, Neumeister, Peter, Strohmaier, Heimo, Krause, Robert, Buchheidt, Dieter, Hoenigl, Martin

“…•Blood and BALF biomarkers for diagnosis of invasive aspergillosis were evaluated.•Biomarkers showed overall better performance in BALF compared to blood.•In…”
Get full text